SCYNEXIS to Join Guggenheim Innovation Conference in Boston

Senior leaders from the company are set to participate in a series of meetings and a fireside chat this November.

Updated on Oct. 29, 2026 in Healthcare

Isometric editorial illustration of a modern, geometric research facility corridor, representing a professional healthcare industry innovation environment.
SCYNEXIS executives will attend the 3rd Annual Guggenheim Healthcare Innovation Conference in Boston from November 9-11, 2026, to engage with stakeholders. AI Illustration. Upload story photo >

SCYNEXIS leadership will attend the 3rd Annual Guggenheim Healthcare Innovation Conference in Boston from November 9-11, 2026. The program includes one-on-one meetings and a scheduled appearance by executives.

Why it matters

The company presence at this event provides a forum for leadership to engage with stakeholders during the three-day healthcare industry gathering.

The fireside chat is scheduled for a 30-minute block from 2:30 p.m. to 3:00 p.m. ET on November 9, 2026. A replay of the event will be accessible to the public for 90 days following the conclusion of the conference.

The players

SCYNEXIS

A biotechnology company headquartered in Jersey City, N.J., that focuses on the development of novel therapies for infectious diseases.

Guggenheim

A global financial services firm that organizes healthcare-focused innovation conferences to connect industry leaders with institutional investors.

The details

Executives from the Jersey City-based firm will hold one-on-one meetings with attendees on November 9 and 10. A live webcast will be available for those unable to attend the fireside chat in person.

Timeline

  1. November 9, 2026: The fireside chat and one-on-one meetings begin.

  2. November 9-10, 2026: SCYNEXIS conducts one-on-one meetings.

  3. November 9-11, 2026: The 3rd Annual Guggenheim Healthcare Innovation Conference takes place.

Market Landscape

Participation in events like the Guggenheim Healthcare Innovation Conference allows mid-cap pharmaceutical companies to maintain visibility among institutional investors. This trend reflects the broader industry move toward direct engagement strategies to secure capital and build institutional partnerships.

Investors and stakeholders can monitor the company's progress through the provided live webcast of the fireside chat. This access allows the public to evaluate corporate commentary and strategic updates directly from the event without needing to attend in person.

The takeaway

Interested parties should note that the fireside chat will be broadcast live for remote access. Following the event, the company will host a replay of the discussion for three months, providing a window to review key leadership updates.

Further reading

For more on the region's industry developments, visit the Boston Healthcare section.

Source note: This article includes information reported by The Manila times.